Purchase Order 75N95023P00400

Award Date 7/1/23
Potential Completion Date 6/30/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02109, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services, awarded a firm-fixed-price purchase order contract to Chemaxon LLC for annual license renewals of the JChem Oracle Cartridge and Marvin JS software. The $56,418.00 contract will provide the AIMS (ATDP Information Management System) application with access to these critical cheminformatics tools from July 1, 2024 through June 30, 2025, with potential...
This is a $90,800.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Chemaxon LLC, a foreign-owned for-profit limited liability company. The contract, which has a completion date of September 29, 2023, is for the provision of ChemAxon software licenses, including JChem Oracle Cartridge, Marvin JS, JChem Base, and Instant JChem Enterprise. These specialized...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded a $87,500.00 firm-fixed-price purchase order to Chemaxon LLC for a 5-year renewal and support of cheminformatics software licenses. The software, which includes products like JChem Oracle Cartridge, Marvin JS, and Instant JChem Enterprise, supports NCATS' initiatives in biotechnology and pharmaceutical research, such as the Preclinical Screening Platform...
This is a $109,853.26 firm fixed price purchase order awarded by the National Institute on Drug Abuse, a component of the U.S. Department of Health and Human Services, to Clarivate Analytics (Us) LLC. The contract provides a user license and subscription to the OFF-X (Translational Safety/Toxicology) and Cortellis Drug Discovery Intelligence software with the Biomarkers Module for the period of April 1, 2024 through March 31, 2025, with a total contract period of performance through March 31,...
This firm-fixed-price federal contract award, valued at $78,000.00, was made by the National Institute on Drug Abuse (NIDA) to Schrodinger LLC, a subsidiary of Schrodinger, Inc. The contract is for the purchase of software licenses for Schrodinger's molecular modeling products, including FFBuilder, Jaguar, KNIME, Maestro, OPLS, MacroModel, Desmond GPU, and Prime. The award was made on a sole-source basis without any set-aside designations, leveraging the unique capabilities of Schrodinger's...
Chemaxon LLC has been awarded a $23,865 firm fixed price purchase order by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide Chemaxon software licenses for use across the NIH's Protein Structure Prediction Pipeline and Enhanced Therapeutics Structure Prediction programs through September 2024. The licenses will support the NIH's efforts to advance understanding of neurological disorders and develop new treatments. As the prime contractor,...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed price purchase order contract to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for a Drug Research Advisor subscription, Off-X (Translational Safety/Toxicology) and Cortellis Drug Discovery Intelligence software with Biomarkers Module. The period of performance is April 1, 2021 to March 31, 2022, with two one-year option periods. The potential...
The National Library of Medicine (NLM) has awarded a $237,073.66 firm-fixed-price purchase order to OpenEye Scientific Software, Inc. for the renewal of licenses and software support for the Lexichem TK, OEChem TK, and Quacpac TK software products. This sole-source award, which does not have a set-aside designation, provides the NLM access to these proprietary molecular modeling and cheminformatics software tools that support the agency's PubChem search system and cheminformatics research...
The National Institute on Drug Abuse (NIDA) awarded a $198,641.93 firm-fixed-price purchase order to The MathWorks, Inc. for institute-wide licenses for the MATLAB and Simulink software suite. The contract is for a 1-year base period from September 1, 2024 through August 31, 2025, with two 1-year option periods, for a total potential period of performance through August 31, 2027. This non-competitive contract was issued as a sole-source procurement, as MATLAB is the only software capable of...
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed-price purchase order to Xemistry GmbH, a for-profit organization, for the renewal of software support and maintenance for the CACTVS Chemoinformatics Toolkit. The contract has a potential value of $123,050.00 and a completion date of July 19, 2023. This contract was awarded on a sole-source basis under simplified acquisition procedures, as the...

This sole source contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemaxon LLC is for annual license renewals of JChem Oracle Cartridge and Marvin JS software. Valued at $10,490, the firm fixed price contract provides 100 user licenses for both the JChem Oracle Cartridge and Marvin JS Library from July 1, 2023 through June 30, 2024 with an additional four 12-month option periods. The software licenses are required to support the Addiction Treatment Drug Program Information Management System application used by NIDA staff for chemical structure and metadata management of proprietary substances received from external entities. As the licenses are proprietary to Chemaxon and no other vendor can meet requirements, the award was made on a non-competitive basis under the authority of Federal Acquisition Regulation Part 8.405-6.

Generated 12/20/23, 11:31 AM